COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

FDA approves remdesivir to treat high-risk outpatients with COVID-19

Those approved to receive the drug can do so outside of traditional hospital settings, including at skilled nursing facilities, home healthcare and other outpatient clinics such as infusion centers.

COVID-19 coronavirus burnout depression pandemic

People with symptoms of depression more likely to believe COVID vaccine misinformation

Nearly 25% of adults in the U.S. report experiencing such symptoms during the pandemic, signaling a need to address this rising mental health crisis.

Thumbnail

Echocardiography and lung ultrasound a helpful combination for assessing pneumonia caused by COVID-19

Using both cardiac and pulmonary ultrasound can help clinicians track disease progression. 

Thumbnail

Cardiac dysfunction, arrhythmias common among recovered COVID-19 patients

Monitoring the heart rhythm of patients who have fully recovered from COVID-19 might provide significant value, researchers wrote. 

COVID-19 congress coronavirus Washington

HHS earmarks $103M to curtail burnout, alleviate healthcare workforce shortages

The grants will be handed out to 45 recipients and will help hospitals deal with the continued influx of patients suffering from COVID-19.

auditorium conference

COVID-19 claims another in-person medical imaging conference

The Association for Medical Imaging Management is shelving its February show in Savannah, Georgia, citing ongoing challenges stemming from the latest variant.

Heparin shows promise as an effective COVID-19 treatment

The drug, commonly used to treat blood clots, could give physicians another tool in the battle against COVID-19—but much more research is still required. 

Thumbnail

Children with COVID-related MIS-C fully recover within months

Researchers analyzed data from 60 children, describing the group's recovery as "excellent."